Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

5 Biotechs Drawing Buyout Buzz in 2018

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:BioPharma

Here are five possible acquisition targets to keep an eye on. Source: BioSpace

Continue Reading5 Biotechs Drawing Buyout Buzz in 2018

Novartis Poised for Growth as CEO Hands Baton to Successor

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:BioPharma

Narasimhan takes over the role of CEO in February as current CEO Joe Jimenez retires. Source: BioSpace

Continue ReadingNovartis Poised for Growth as CEO Hands Baton to Successor

Why This Heart Drug Could Be a $5B Blockbuster for Novartis

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:BioPharma

Entresto, introduced in 2015, got off to a slow start but brought in $507 million in revenue last year. Source: BioSpace

Continue ReadingWhy This Heart Drug Could Be a $5B Blockbuster for Novartis

AI Biotech Startup XtalPi Scores $15M From Google, Tencent and Sequoia

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:BioPharma

The latest funding round gives XtalPi $20M in the bank, which the company said makes it "one of the top-funded AI-powered biotechs." Source: BioSpace

Continue ReadingAI Biotech Startup XtalPi Scores $15M From Google, Tencent and Sequoia

Hong Kong Drugmaker Warned for Quality Control, Procedural Shortcomings

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:Drug Industry Daily

Wong Lap Kwong Medicine Company drew a warning from the FDA for failing to identify active pharmaceutical ingredients and to establish procedures for numerous basic functions in its Hong Kong…

Continue ReadingHong Kong Drugmaker Warned for Quality Control, Procedural Shortcomings

Lawsuit Claims FDA Hurt Research Firm’s Reputation

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:Drug Industry Daily

A drug research firm is suing the FDA for $50 million, arguing the agency issued a disciplinary letter that “annihilated” the company based on evidence fabricated by a rogue employee.…

Continue ReadingLawsuit Claims FDA Hurt Research Firm’s Reputation

DEA Regulation Conforms With CARA to Combat Opioid Crisis

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:Drug Industry Daily

The Drug Enforcement Administration issued a final rule expanding the types of practitioners who may temporarily prescribe narcotic drugs for opioid addiction treatment and improving treatment availability in underserved areas.…

Continue ReadingDEA Regulation Conforms With CARA to Combat Opioid Crisis

CBER’s 2018 Guidance Agenda Features Gene Therapies, Blood Products

  • Post author:Sam
  • Post published:January 23, 2018
  • Post category:Drug Industry Daily

CBER’s agenda for 2018 states that it is considering the release of more than a dozen guidance documents, including new draft guidance on testing retroviral gene therapy products and on…

Continue ReadingCBER’s 2018 Guidance Agenda Features Gene Therapies, Blood Products

Bay Area's GigaGen Moves to New Space to Accommodate Growth

  • Post author:Sam
  • Post published:January 22, 2018
  • Post category:BioPharma

GigaGen completed relocation to One Tower Place in late December 2017. Source: BioSpace

Continue ReadingBay Area's GigaGen Moves to New Space to Accommodate Growth

3 Biotechs That Have Doubled Investors' Money in Less Than a Year

  • Post author:Sam
  • Post published:January 22, 2018
  • Post category:BioPharma

Having a stock double in value is a good thing. Source: BioSpace

Continue Reading3 Biotechs That Have Doubled Investors' Money in Less Than a Year
  • Go to the previous page
  • 1
  • …
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.